By Brian DiSabatino, President EDiS, Wilmington
The Astra Zeneca restructuring in Delaware was a big blow, but it wasn’t news. When Delaware set out on an economic development strategy to encourage AZ, as did many other states, their motives were good and their logic sound.
But nearly minutes after the strategy was launched, the market around the life science industry began to shift, much like when the market shifted the day Betamax woke up to a world filled with DVDs. And like the Betamax revolution, it looks like the changes in the life science industry are here to stay.
Click on the link below to read the remainder of Brian’s blog entry:
via EDiS Out Loud.
